Class / Patent application number | Description | Number of patent applications / Date published |
424258100 | Salmonella (e.g., Salmonella typhimurium, etc.) | 20 |
20080220022 | Salmonella Vaccine - The present invention relates to the field of vaccination against | 09-11-2008 |
20080260783 | COMPOSITION AND METHOD FOR CONTROLLING INTESTINAL PATHOGENIC ORGANISMS - An antigen composition for stimulating an immune response in an inoculated avian species to at least one intestinal pathogenic organism includes naturally-occurring wild | 10-23-2008 |
20090175913 | AMMENDOLA/SALMONELLA ENTERICA STRAINS OF REDUCED PATHOGENICITY, METHOD FOR THEIR PREPARATION AND USES THEREOF - The invention concerns novel | 07-09-2009 |
20090208534 | ATTENUATED SALMONELLA AS A DELIVERY SYSTEM FOR SIRNA-BASED TUMOR THERAPY - The invention relates to an attenuated | 08-20-2009 |
20100136060 | METHODS OF REDUCING PORCINE CIRCOVIRUS-ASSOCIATED DISEASE OUTBREAKS - The present invention relates to the use of an immunogenic composition that comprises a | 06-03-2010 |
20110033501 | RECOMBINANT BACTERIUM CAPABLE OF ELICITING AN IMMUNE RESPONSE AGAINST ENTERIC PATHOGENS - The present invention relates to a recombinant bacterium that is capable of eliciting an immune response against at least two enteric pathogens, without substantially inducing an immune response specific to the serotype of the bacterium. The invention also relates to methods of making such a bacterium and vaccines and methods of using such a bacterium. | 02-10-2011 |
20110256181 | RECOMBINANT BACTERIUM CAPABLE OF ELICITING A PROTECTIVE IMMUNE RESPONSE AGAINST C. PERFRINGENS - The present invention encompasses recombinant bacteria and immunogenic compositions comprising the bacteria. The immunogenic composition may be used to induce an immune response against | 10-20-2011 |
20120003269 | Compositions Produced Using Enteric Pathogens and Methods of Use - The present invention provides compositions including polypeptides having the characteristics of polypeptides expressed by a reference microbe such | 01-05-2012 |
20120114698 | SALMONELLA MARKER VACCINE - The present invention relates to a | 05-10-2012 |
20130017219 | PURIFICATION OF BACTERIAL VESICLESAANM Di Cioccio; VitoAACI Rapolano TermeAACO ITAAGP Di Cioccio; Vito Rapolano Terme ITAANM Colucci; Anna MariaAACI Martina FrancaAACO ITAAGP Colucci; Anna Maria Martina Franca ITAANM Saul; Allan JamesAACI Castellina in ChiantlAACO ITAAGP Saul; Allan James Castellina in Chiantl IT - A two stage size filtration process is used to purify immunogenic bacterial vesicles. A first step separates the vesicles from intact bacteria based on their different sizes, with the smaller vesicles passing into the filtrate (permeate). A second step then uses a finer filter to remove smaller contaminants, with the vesicles remaining in the retentate. This two stage process is extremely simple to operate but has been shown to give vesicles of high purity. | 01-17-2013 |
20130028936 | TLR 4 AND 9 RECEPTORS AGONISTS FOR PREVENTING SEPTIC COMPLICATIONS OF POST-TRAUMATIC IMMUNODEPRESSION IN PATIENTS HOSPITALIZED FOR SEVERE TRAUMATIC INJURIES - The present invention concerns a pharmaceutical composition comprising at least one agonist of at least one Toll Like receptor (TLR) chosen from TLR 4 and 9, for use in the prophylactic treatment of septic complications of post-traumatic systemic immunodepression in a patient who has suffered one or more severe traumatic injuries and is hospitalized in particular in an intensive care unit. Preferably, said TLR 4 agonist is monophosphoryl lipid A (MPLA) or deacylated 3-O-monophosphoryl lipid A (3D-MPLA) and said TLR 9 agonist is a CpG oligodeoxynucleotide (CpG ODN). | 01-31-2013 |
20130052230 | SALMONELLA VACCINE - The present invention relates to novel | 02-28-2013 |
20130202643 | Avirulent Salmonella Gallinarum Variants and Pharmaceutical Composition Using the Same - The present invention relates to avirulent | 08-08-2013 |
20130337013 | RECOMBINANT BACTERIUM COMPRISING A TOXIN/ANTITOXIN SYSTEM - The present invention encompasses recombinant bacteria suitable for live attenuated vaccines, and methods of use thereof. One aspect of the present invention encompasses a recombinant | 12-19-2013 |
20140186401 | TUMOR ASSOCIATED VACCINES AND COMPOSITIONS FOR DISRUPTING TUMOR-DERIVED IMMUNOSUPPRESSION FOR USE IN COMBINATION CANCER IMMUNOTHERAPY - In one embodiment, a single modality cancer immunotherapy regimen that includes a therapeutic composition is provided. Such a therapeutic composition may include a | 07-03-2014 |
20140242117 | Vaccine Composition Capable of Inducing Memory Antibody Response from Single Point Immunization - The present investigation relates to entrapment of carbohydrate antigen such as Vi polysaccharide of | 08-28-2014 |
20140370057 | ATTENUATED LIVE BACTERIA WITH INCREASED ACID RESISTANCE AND METHODS OF USE THEREOF - The present invention relates to inducing acid resistance in a bacterium and methods of increasing the acid resistance of an acid sensitive bacterium. | 12-18-2014 |
20150290310 | CROSS-PROTECTING SALMONELLA VACCINES - The present invention discloses that | 10-15-2015 |
20150297705 | PREPARATION OF LIVE VACCINES - Described is a method for the generation of a live vaccine containing stable bacteria carrying at least three attenuating mutations and a vaccine containing bacteria obtained by said method. | 10-22-2015 |
20150359880 | DUAL ADJUVANT VACCINE COMPOSITIONS, PREPARATION AND USES - The present invention relates to vaccines comprising an effective amount of at least one antigen in a water-in-oil-in-water (WOW) emulsion and an additional adjuvant, and to the methods of preparation and uses thereof. | 12-17-2015 |